CEO of Pila Pharma increases share holding to over a third

Dorte X. Gram, the founder and CEO of Danish-Swedish Pila Pharma has purchased shares in the diabetes firm, giving her 31-percent ownership. The price per share was less than in summer when the firm went public, and Gram says that at the current price, there is "no better investment than this one."
Photo: Jenny Leyman / Pila Pharma / PR
Photo: Jenny Leyman / Pila Pharma / PR
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY DANIEL PEDERSEN

On Monday this week, CEO Dorte X. Gram's belief in Pila Pharma's future manifested itself strongly, as she purchased a considerable portion of shares increasing her ownership to almost a third, the firm reported in a press release on Tuesday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading